Okapi Sciences Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 10
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $45.6M
Latest Deal Amount

Okapi Sciences General Information


Developer of drugs to treat viral infections for both pets and livestock. The company engages itself in the research, development, promotion and marketing of anti-viral drugs for veterinary applications, offering vet doctors with the latest drugs.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Parent Company
Primary Office
  • Ambachtenlaan 1
  • Heverlee
  • 3001 Leuven
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Okapi Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Jan-2014 $45.6M 000.00 000.00 Completed Generating Revenue
3. Angel (individual) 14-Nov-2011 00000 000.00 00000 Completed Product Development
2. Angel (individual) 30-Nov-2010 $184K $12.1M 00000 Completed Product Development
1. Early Stage VC 17-Oct-2008 $11.9M $11.9M Completed Product Development
To view Okapi Sciences’s complete valuation and funding history, request access »

Okapi Sciences Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference A 00,000 00.00 00.00 00.00 00.000
Ordinary 0,000 000.00 000.00 00 000.00 00.000
To view Okapi Sciences’s complete cap table history, request access »

Okapi Sciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Okapi Sciences Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agri Investment Fund PE/Buyout Minority 000 0000 000000 0
BNP Paribas Fortis Private Equity Growth/Expansion Minority 000 0000 000000 0
KBC Arkiv PE/Buyout Minority 000 0000 000000 0
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
Neon Private Equity PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »